Go to content

Everolimus (Votubia) for the indication 'treatment of patients aged 3 years and older with subependymal giant cell astrocytoma associated with tuberous sclerosis complex

The use of everolimus for the treatment of patients aged 3 years and older with subependymal giant cell astrocytomas (SEGA) associated with tuberous sclerosis complex (TSC), who require therapeutic intervention but are not amenable to surgery, has a therapeutic added value in comparison with best supportive care.

This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.

Download "Everolimus (Votubia) for the indication 'treatment of patients aged 3 years and older with subependymal giant cell astrocytoma associated with tuberous sclerosis complex"

PDF document | 75 kB

Report | 23-01-2012